E-viri
PDF
Recenzirano
Odprti dostop
-
Schreiber, Stuart L; Shamji, Alykhan F; Clemons, Paul A; Hon, Cindy; Koehler, Angela N; Munoz, Benito; Palmer, Michelle; Stern, Andrew M; Wagner, Bridget K; Powers, Scott; Lowe, Scott W; Guo, Xuecui; Krasnitz, Alex; Sawey, Eric T; Sordella, Raffaella; Stein, Lincoln; Trotman, Lloyd C; Califano, Andrea; Dalla-Favera, Riccardo; Ferrando, Adolfo; Iavarone, Antonio; Pasqualucci, Laura; Silva, José; Stockwell, Brent R; Hahn, William C; Chin, Lynda; DePinho, Ronald A; Boehm, Jesse S; Gopal, Shuba; Huang, Alan; Root, David E; Weir, Barbara A; Gerhard, Daniela S; Zenklusen, Jean Claude; Roth, Michael G; White, Michael A; Minna, John D; MacMillan, John B; Posner, Bruce A
Nature biotechnology, 201009, 2010-Sep, 2010-9-00, 20100901, Letnik: 28, Številka: 9Journal Article
Orienting cancer drug discovery to the patient requires relating the genetic features of tumors to acquired gene and pathway dependencies and identifying small-molecule therapeutics that target them. PUBLICATION ABSTRACT
